Foster & Motley Inc. Purchases Shares of 1,448 Intuitive Surgical, Inc. $ISRG

Foster & Motley Inc. purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 1,448 shares of the medical equipment provider’s stock, valued at approximately $576,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Brighton Jones LLC grew its stake in shares of Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after purchasing an additional 731 shares in the last quarter. Sivia Capital Partners LLC raised its stake in shares of Intuitive Surgical by 3.8% during the second quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock valued at $504,000 after purchasing an additional 34 shares in the last quarter. Schnieders Capital Management LLC. lifted its holdings in Intuitive Surgical by 38.0% in the second quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock worth $529,000 after purchasing an additional 268 shares during the period. Osterweis Capital Management Inc. acquired a new stake in Intuitive Surgical in the second quarter worth about $200,000. Finally, Main Street Financial Solutions LLC grew its position in Intuitive Surgical by 92.4% in the 2nd quarter. Main Street Financial Solutions LLC now owns 2,929 shares of the medical equipment provider’s stock valued at $1,592,000 after buying an additional 1,407 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Trading Up 1.7%

Shares of NASDAQ ISRG opened at $397.72 on Thursday. Intuitive Surgical, Inc. has a twelve month low of $328.57 and a twelve month high of $603.88. The firm has a 50-day moving average of $389.89 and a two-hundred day moving average of $438.02. The company has a market capitalization of $140.51 billion, a price-to-earnings ratio of 45.56, a PEG ratio of 2.83 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, topping analysts’ consensus estimates of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The business had revenue of $2.89 billion for the quarter, compared to the consensus estimate of $2.83 billion. During the same period in the previous year, the firm earned $1.81 EPS. The business’s revenue for the quarter was up 18.4% on a year-over-year basis. As a group, research analysts predict that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In other news, EVP Gary Loeb sold 400 shares of the firm’s stock in a transaction on Monday, August 10th. The stock was sold at an average price of $379.00, for a total transaction of $151,600.00. Following the completion of the sale, the executive vice president directly owned 5,320 shares of the company’s stock, valued at $2,016,280. This trade represents a 6.99% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Mark Brosius sold 77 shares of Intuitive Surgical stock in a transaction on Wednesday, August 19th. The stock was sold at an average price of $394.26, for a total value of $30,358.02. Following the completion of the transaction, the executive vice president owned 1,035 shares in the company, valued at $408,059.10. The trade was a 6.92% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 17,224 shares of company stock worth $6,994,426. 0.60% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research firms have commented on ISRG. HSBC downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price target on the stock. in a research report on Thursday, July 30th. Evercore set a $430.00 price objective on shares of Intuitive Surgical in a report on Monday, July 6th. Sanford C. Bernstein reiterated an “outperform” rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. Piper Sandler set a $357.44 target price on Intuitive Surgical in a report on Monday, July 27th. Finally, TD Cowen downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Tuesday, July 28th. Twenty-two investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average target price of $508.68.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical is expanding its Asia-Pacific manufacturing footprint with a new plant in Penang, Malaysia. The facility is expected to increase production capacity and support regional demand for robotic-assisted surgery, reinforcing the company’s long-term growth strategy. Intuitive Surgical Expands Manufacturing Footprint in Asia Pacific
• Positive Sentiment: Analysts highlighted the growing importance of ISRG’s software strategy. New da Vinci 5 features, software renewals and service-related recurring revenue could deepen customer relationships, improve revenue visibility and make the digital ecosystem an increasingly important growth driver alongside robot sales. Is ISRG’s Software Strategy Becoming as Important as Its Robots?
• Neutral Sentiment: A comparison with Abbott Laboratories noted that Abbott’s consistent recent growth and raised outlook may appeal to investors seeking steadier performance, while Intuitive Surgical offers higher-quality, premium growth potential. The comparison does not indicate a change in ISRG’s fundamentals but underscores valuation and execution expectations. Abbott vs. Intuitive Surgical: Is Consistent Growth Better Than Premium Growth?
• Negative Sentiment: Recent coverage said investors are reassessing Intuitive Surgical’s long-term growth prospects after its latest earnings, contributing to a major annual sell-off. The concern is that procedure-volume growth and future expansion may not justify ISRG’s still-premium valuation. Intuitive Surgical Stock Is Having Its Worst Year Since 2008
• Negative Sentiment: Executive Vice President Mark Brosius sold shares in two transactions under a pre-arranged Rule 10b5-1 trading plan. The sales modestly reduced his holdings, but the scheduled nature of the transactions makes them a limited signal of insider sentiment. SEC insider transaction filing

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.